Safe prescribing in cancer patients during the COVID-19 pandemic: A new initiative from the UK Cancer Coronavirus Project (UKCCP) team
Int J Cancer
.
2023 Mar 15;152(6):1275-1277.
doi: 10.1002/ijc.34387.
Epub 2022 Dec 8.
Authors
Nathan Appanna
1
,
Grisma Patel
2
,
Emma Burke
3
,
Alexander Burnett
4
,
James Clark
5
,
Rosie Mew
6
,
Sam Khan
7
,
Martin Little
3
,
Justin Liu
8
,
Hari Panneerselvam
9
,
Vijay Patel
10
,
James Platt
8
,
Michael Tilby
11
,
Isabella Watts
12
,
Catherine Harper-Wynne
13
,
Lennard Y W Lee
3
Affiliations
1
University of Oxford, Oxford, UK.
2
Cancer Division, UCL Cancer Institute, University College London, London, UK.
3
Oxford University Hospitals NHS Trust, London, UK.
4
Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
5
Department of Surgery and Cancer, Imperial College London, London, UK.
6
Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
7
Leicester Cancer Research Centre, University of Leicester, Leicester, UK.
8
Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
9
Department of Oncology, Wye Valley NHS Foundation Trust, Herefordshire, UK.
10
NHS UK and Improvement, London, UK.
11
Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
12
Department of Academic Oncology, Royal Free Hospital, London, UK.
13
Kent Oncology Centre, Kent and Medway Medical School, University of Kent, Kent, UK.
PMID:
36454180
PMCID:
PMC9877804
DOI:
10.1002/ijc.34387
Abstract
Publication types
Letter
MeSH terms
COVID-19*
Humans
Neoplasms* / drug therapy
Neoplasms* / epidemiology
Pandemics
SARS-CoV-2
United Kingdom / epidemiology